Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Arteméter más lumefantrina (régimen de seis dosis) para el tratamiento del paludismo por P. falciparum no complicado

Información

DOI:
https://doi.org/10.1002/14651858.CD005564Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 19 octubre 2005see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Enfermedades infecciosas

Clasificada:
  1. Actualización no planificada

    Other

    No update planned. The six‐dose regimen is now used as first‐line treatment. It is included as a comparator in other Cochrane Reviews, for example Zani 2014 https://doi.org/10.1002/14651858.CD010927/full

    Evaluada: 8 May 2019

Copyright:
  1. Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Aika AA Omari

    Correspondencia a: Alder Hey Children's Hospital, Liverpool, UK

    [email protected]

    [email protected]

  • Carrol L Gamble

    Centre for Medical Statistics and Health Evaluation, University of Liverpool, Liverpool, UK

  • Paul Garner

    International Health Group, Liverpool School of Tropical Medicine, Liverpool, UK

Contributions of authors

Aika Omari and Carrol Gamble extracted and analysed data, and drafted the review. Paul Garner helped prepare the review.

Sources of support

Internal sources

  • Liverpool School of Tropical Medicine, UK.

External sources

  • Department for International Development, UK.

Declarations of interest

Paul Garner and Carrol Gamble (né Preston) were unpaid technical advisers to a World Health Organization meeting on 19 and 20 February, 2001 considering efficacy and effectiveness studies of co‐artemether‐lumefantrine. The World Health Organization paid for their travel and accommodation, and a representative of Novartis chaired the meeting.
Aika Omari: none known

Acknowledgements

This document is an output from a project funded by the UK Department for International Development (DFID) for the benefit of developing countries. The views expressed are not necessarily those of DFID.

Version history

Published

Title

Stage

Authors

Version

2005 Oct 19

Artemether‐lumefantrine (six‐dose regimen) for treating uncomplicated falciparum malaria

Review

Aika AA Omari, Carrol L Gamble, Paul Garner

https://doi.org/10.1002/14651858.CD005564

Notes

2011, Issue 9: The Cochrane Infectious Diseases Group are piloting a system to indicate whether the question is currently relevant, and the status of the review with regards to being up to date.

For relevance, we classify reviews into:

  • historical question, where an intervention or policy has been superseded by new medical developments (such as a new drug),

  • current question, which are still relevant to current policy or practice.

For status, we have three categories, with an explanation after each: “up to date”; “update pending”; “no update intended”.

For this review, we have categorised the review as: Current question ‐ no update intended (topic covered in another review. Refer to: Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin‐based combination therapy for treating uncomplicated malaria. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007483. DOI: 10.1002/14651858.CD007483.pub2.)

2005, Issue 4 (first review version): We divided the original review on artemether‐lumefantrine (Omari 2002; Omari 2003) into two separate reviews, one of the six‐dose regimen (this review) and the other of the four‐dose regimen (Omari 2006), and added seven new trials.